SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-066407
Filing Date
2023-11-28
Accepted
2023-11-28 16:14:11
Documents
13
Period of Report
2023-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sctl-20231121.htm   iXBRL 8-K 46149
2 EX-10.1 sctl-ex10_1.htm EX-10.1 30863
  Complete submission text file 0000950170-23-066407.txt   195955

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sctl-20231121_lab.xml EX-101.LAB 13466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sctl-20231121_pre.xml EX-101.PRE 9908
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sctl-20231121.xsd EX-101.SCH 2481
7 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20231121_htm.xml XML 4730
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 231446555
SIC: 2834 Pharmaceutical Preparations